Brain Injury and Dysmaturation in Newborns with Congenital Heart Disease Born Preterm

早产先天性心脏病新生儿的脑损伤和发育不良

基本信息

项目摘要

Brain Injury and Dysmaturation in Newborns with Congenital Heart Disease Born Preterm. Abstract: Preterm birth and congenital heart disease (CHD) are two of the most common sources of perinatal morbidity in high resource countries. Both conditions are associated with acquired brain injury and adverse neurodevelopmental outcomes. Very little is known about the combined risk for newborns with congenital heart disease that are born preterm and how this risk is affected by variable approaches to palliative or definitive surgical strategies to repair heart defects. In addition to brain injury, an increasing number of genetic anomalies have been identified in CHD that may contribute to ND outcomes. Our extensive experience imaging term babies with CHD and preterm babies without CHD, combined with high and increasing volume of this vulnerable population at our two centers uniquely positions us to describe the risk and magnitude of acquired brain injury as well as comparative brain development in CHD newborns born preterm with respect to intervention strategies. Our long-term goal is to optimize neurodevelopmental outcomes. In this proposal, we will leverage cross-center practice variability in timing and choice of surgical interventions, palliative versus definitive, to determine the association of surgical intervention strategy with brain development and risk of brain injury. We will also perform a comprehensive genetic evaluation to determine how genetic anomalies alter susceptibility to brain injury and ND outcome.
早产儿先天性心脏病新生儿脑损伤与脑发育不良。 摘要: 早产和先天性心脏病(CHD)是围产期发病率的两个最常见的来源 在高资源国家。这两种情况都与获得性脑损伤和不良反应有关。 神经发育结果。关于新生儿先天性心脏病的综合风险知之甚少。 早产儿的心脏病以及这种风险如何受到姑息治疗或 决定性的外科手术策略来修复心脏缺陷。除了脑损伤,越来越多的遗传 在CHD中已经确定了可能导致ND结局的异常。我们丰富的经验 对患有CHD的足月儿和未患CHD的早产儿进行成像,结合高且不断增加的 这两个中心的弱势群体使我们能够独特地描述 获得性脑损伤以及早产CHD新生儿的脑发育比较 干预策略。我们的长期目标是优化神经发育结果。在本提案中,我们 将利用跨中心实践在手术干预时机和选择方面的差异性,姑息性与 明确的,以确定手术干预策略与脑发育和脑损伤风险之间的关系。 损伤我们还将进行全面的遗传评估,以确定遗传异常如何改变 脑损伤易感性和ND结局。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick Sean McQuillen其他文献

Patrick Sean McQuillen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick Sean McQuillen', 18)}}的其他基金

Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10468851
  • 财政年份:
    2021
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10248820
  • 财政年份:
    2021
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10393871
  • 财政年份:
    2021
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10670260
  • 财政年份:
    2021
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10670202
  • 财政年份:
    2021
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10470939
  • 财政年份:
    2021
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Research to Validate Biomarkers of Pediatric ARDS
验证儿科 ARDS 生物标志物的合作研究
  • 批准号:
    10056715
  • 财政年份:
    2014
  • 资助金额:
    $ 89.5万
  • 项目类别:
Repair in High Risk Newborns with Congential Heart Disease
患有先天性心脏病的高危新生儿的修复
  • 批准号:
    8653646
  • 财政年份:
    2014
  • 资助金额:
    $ 89.5万
  • 项目类别:
Collaborative Research to Validate Biomarkers of Pediatric ARDS
验证儿科 ARDS 生物标志物的合作研究
  • 批准号:
    9187848
  • 财政年份:
    2014
  • 资助金额:
    $ 89.5万
  • 项目类别:
Repair after Neonatal Brain Injury
新生儿脑损伤后的修复
  • 批准号:
    9198886
  • 财政年份:
    2014
  • 资助金额:
    $ 89.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了